The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Toshi.Suzuki@glasgow.ac.uk
Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD
Wicks, A. T. et al. (2026) CBL ubiquitin ligase targets translation as a degrader E3. Chemical Science, 17(8), pp. 4061-4074. (doi: 10.1039/d5sc06141e) (PMID:41503015) (PMCID:PMC12774438)
Churchhouse, A. M.D. et al. (2024) Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression. Oncogene, 43(42), pp. 3094-3107. (doi: 10.1038/s41388-024-03135-9) (PMID:39242821)
Wicks, A. T. et al. (2026) CBL ubiquitin ligase targets translation as a degrader E3. Chemical Science, 17(8), pp. 4061-4074. (doi: 10.1039/d5sc06141e) (PMID:41503015) (PMCID:PMC12774438)
Churchhouse, A. M.D. et al. (2024) Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression. Oncogene, 43(42), pp. 3094-3107. (doi: 10.1038/s41388-024-03135-9) (PMID:39242821)